Lineage Cell Therapeutics
LCTX
#8903
Rank
A$0.16 B
Marketcap
$0.71
Share price
-6.12%
Change (1 day)
-58.24%
Change (1 year)

Earnings for Lineage Cell Therapeutics (LCTX)

Earnings in 2024 (TTM): -A$32.76 Million

According to Lineage Cell Therapeutics 's latest financial reports the company's current earnings are A$9.49 Million. , an increase over its 2023 earnings that were of -A$38.45 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lineage Cell Therapeutics from 1992 to 2024

Annual earnings

Year Earnings Change
2024 -A$33.39 Million-13.16%
2023 -A$38.45 Million9.83%
2022 -A$35.01 Million-54.24%
2021 -A$76.49 Million86.07%
2020 -A$41.11 Million-31.97%
2019 -A$60.43 Million-5.42%
2018 -A$63.89 Million1.1%
2017 -A$63.2 Million-31.06%
2016 -A$91.66 Million-10.38%
2015 -A$0.11 Billion29.69%
2014 -A$78.87 Million31.68%
2013 -A$59.9 Million
2011 -A$29.07 Million89.78%
2010 -A$15.32 Million206.06%
2009 -A$5.01 Million-0.58%
2008 -A$5.04 Million164.89%
2007 -A$1.91 Million-30.22%
2006 -A$2.73 Million
2002 -A$3.17 Million-41.04%
2001 -A$5.37 Million-32.04%
2000 -A$7.9 Million-11.85%
1999 -A$8.96 Million
1997 -A$5.76 Million12.12%
1996 -A$5.13 Million106.25%
1995 -A$2.49 Million-11.11%
1994 -A$2.8 Million50%
1993 -A$1.87 Million20%
1992 -A$1.56 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$0.23 Billion 565.31%๐Ÿ‡บ๐Ÿ‡ธ USA